Found: 3
Select item for more details and to access through your institution.
A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group.
- Published in:
- 1997
- By:
- Publication type:
- journal article
A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children.
- Published in:
- European Journal of Pediatrics, 1997, v. 156, n. 9, p. 693, doi. 10.1007/s004310050692
- By:
- Publication type:
- Article
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 12, p. 2082, doi. 10.1038/sj.leu.2403867
- By:
- Publication type:
- Article